| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |